Drug makers have hiked the price of over 250 drugs in the US so far in 2020, according to new reports.
List view / Grid view
Tecfidera® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis
3 February 2014 | By Biogen Idec
Biogen Idec to begin launching TECFIDERA in initial EU Countries in the coming weeks...
22 November 2013 | By Biogen Idec
This designation will provide 10 years of regulatory exclusivity for TECFIDERA in the European Union...